Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Immunological Challenges and Emerging Strategies in Dengue Virus Vaccine Development.

Created on 16 Nov 2026

Authors

Xuelian Ma, Mengyuan Zhao, Yaqun Xu, Yinghan Jiang, Yang Yang, Luping Lei, Minghui Yang

Published in

Vaccines. Volume 14. Issue 10. Oct 15, 2026. Epub Oct 15, 2026.

Abstract

Dengue is one of the most rapidly spreading arboviral diseases worldwide, and the development of effective vaccines has long been constrained by antibody-dependent enhancement (ADE) and the difficulty of inducing protective immunity against multiple viral serotypes. Although several live-attenuated dengue vaccines have received regulatory approval in different jurisdictions, including Dengvaxia (CYD-TDV), Qdenga (TAK-003), and, more recently, Butantan-DV in Brazil, important challenges remain regarding vaccine safety in relation to pre-vaccination dengue serostatus, balanced cross-serotype protection, and the durability of vaccine-induced immunity. This review focuses on the immunopathogenic mechanisms of dengue virus infection, with particular emphasis on how ADE and immune bias impose critical constraints on vaccine design. We systematically summarize the technological platforms, immunological rationale, and major limitations of licensed and investigational dengue vaccines. Building on this analysis, the potential advantages and remaining challenges of emerging vaccine technologies, particularly mRNA vaccines, in precise antigen design, multivalent immune regulation, and safety optimization are further discussed. This review aims to provide a theoretical basis and strategic reference for the development of next-generation dengue vaccines with improved safety and efficacy.

PMID:
42931431
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement